Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kopelman, Michael D.
1985.
Multiple memory deficits in Alzheimer-type dementia: implications for pharmacotherapy.
Psychological Medicine,
Vol. 15,
Issue. 3,
p.
527.
Keshavan, M. S.
Burton, S.
Murphy, M.
Checkley, S. A.
and
Crammer, J. L.
1985.
Benzhexol Withdrawal and Cholinergic Mechanisms in Depression.
British Journal of Psychiatry,
Vol. 147,
Issue. 5,
p.
560.
Green, A.I.
and
Salzman, C.
1986.
Vol. 10,
Issue. ,
p.
34.
Dilsaver, Steven C
1986.
Pathophysiology of “cholinoceptor supersensitivity” in affective disorders.
Biological Psychiatry,
Vol. 21,
Issue. 8-9,
p.
813.
Kopelman, Michael D.
1986.
The Cholinergic Neurotransmitter System in Human Memory and Dementia: A Review.
The Quarterly Journal of Experimental Psychology Section A,
Vol. 38,
Issue. 4,
p.
535.
Caradoc-Davies, Gillian
Menkes, David B.
Clarkson, Hugh O.
and
Mullen, Paul E.
1986.
A Study of the Need for Anticholinergic Medication in Patients Treated with Long-Term Antipsychotics.
Australian & New Zealand Journal of Psychiatry,
Vol. 20,
Issue. 2,
p.
225.
Dilsaver, Steven C.
1986.
Cholinergic mechanisms in depression.
Brain Research Reviews,
Vol. 11,
Issue. 3,
p.
285.
Fisch, R. Z.
1987.
Trihexyphenidyl abuse: therapeutic implications for negative symptoms of schizophrenia?.
Acta Psychiatrica Scandinavica,
Vol. 75,
Issue. 1,
p.
91.
Craven, John L.
and
Rodin, Gary M.
1987.
Cyproheptadine Dependence Associated with an Atypical Somatoform Disorder.
The Canadian Journal of Psychiatry,
Vol. 32,
Issue. 2,
p.
143.
Miller, E.
Berrios, G.E.
and
Politynska, B.
1987.
The adverse effect of benzhexol on memory in Parkinson's disease.
Acta Neurologica Scandinavica,
Vol. 76,
Issue. 4,
p.
278.
Galletly, Cherrie A.
and
Field, Colin D.
1987.
Learning and Memory Impairment with Benzhexol.
Australian & New Zealand Journal of Psychiatry,
Vol. 21,
Issue. 4,
p.
612.
Holloway, F.
1988.
Prescribing for the Long-term Mentally Ill.
British Journal of Psychiatry,
Vol. 152,
Issue. 4,
p.
511.
Cutting, J.
1988.
Psychiatrie der Gegenwart 6.
p.
365.
Barnes, T. R. E.
1990.
Comment on the WHO Consensus Statement.
British Journal of Psychiatry,
Vol. 156,
Issue. 3,
p.
413.
Hart, Linda L.
Middleton, Robert K.
Mcqueen, Kellie D.
Hidalgo, Hanneli A.
and
Mowers, Robert M.
1990.
Drug Information Analysis Service.
DICP,
Vol. 24,
Issue. 1,
p.
40.
Patel, Shirish
and
Tariot, Pierre N.
1991.
Pharmacologic Models of Alzheimer's Disease.
Psychiatric Clinics of North America,
Vol. 14,
Issue. 2,
p.
287.
O'Keane, V.
O'Flynn, K.
Lucey, J.
and
Dinan, T. G.
1992.
Pyridostigmine-induced growth hormone responses in healthy and depressed subjects: evidence for cholinergic supersensitivity in depression.
Psychological Medicine,
Vol. 22,
Issue. 1,
p.
55.
Teck-Hong, Ong
1992.
The behavioural characteristics and health conditions of drug abusers: some implications for workers in drug addiction.
International Social Work,
Vol. 35,
Issue. 1,
p.
7.
Qureshi, Naseem A.
1992.
Trihexyphenidyl (Artane) Abuse among Saudi Psychiatric Patients.
Annals of Saudi Medicine,
Vol. 12,
Issue. 4,
p.
391.
Dubé, Sanjay
1993.
Biology of Depressive Disorders. Part A.
p.
51.
eLetters
No eLetters have been published for this article.